🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Il nostro viaggio comincia con Antonio Casini, ricercatore presso il CIBIO (Centre for Integrative Biology), comincia con il mondo dei batteri #TEDxBergamo #TEDxWonder #TEDxBergamo2019

.CIBIO - UniTrento ha elaborato un nuovo metodo per correggere due delle mutazioni genetiche che causano la fibrosi cistica trentinostartup.eu/editing-genomi…

Alia Therapeutics is joining #asgct2020 virtually! Thursday 14th May from 5.30 to 6.30 ET our scientists will present two posters (#1092 and #1105) on our latest results on #genomeediting technologies and applications. Come have a look!

We were CRISPR beginners when @sbabrel joined the lab for her MSc. Meanwhile she achieved any kind of gene edit in RPE1 cells. All her secrets ended up in her detailed protocol. Congrats Sabrina and thanks to real experts Anna Cereseto and Antonio Casini doi.org/10.1016/j.xpro… .

Sofinnova Partners announced today three new investments from the Sofinnova Telethon Fund, its early-stage fund dedicated to investments in rare, genetic diseases. #biotech #startups @Telethonitalia hubs.ly/H0Rh6qS0

We have raised additional funding to push forward our #geneediting pipeline to treat #RareDiseases and further implement our core technologies! Among the investors Sofinnova Partners, BiovelocITA, Indaco Venture Partners, @BanorSim and Banca Profilo. sofinnovapartners.com/news/sofinnova…

It is really a great pleasure to have Georges onboard!

We are very pleased to be part of the #BioEquity Europe 2022 Presenting Company Class! Looking forward to meet with top #Leaders in #biopharma in Milan next May.

Great opportunity for doing cutting edge research on one of the hottest topics in gene editing and gene therapy at the moment: delivery!

PNRR vuol dire anche borse di dottorato: grazie ai finanziamenti Next Generation EU mette a disposizione 55 nuovi posti di dottorato per l’anno accademico 2022/23🎓 Scopri i termini di ammissione e ulteriori informazioni sul sito Università di Trento: unitn.it/bandi-phd-pnrr

We’re #hiring. Alia Therapeutics is looking for a #scientist to join the team! Past experience in T cell biology and CAR-T generation is requested, a background on #crispr-based gene editing is a plus. More information on the position in the link below. linkedin.com/jobs/view/3262…

Great news for Alia! Ready to push forward our CRISPR platform and pipeline!

Sofinnova Partners welcomes Letizia Goretti as CEO of Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology. hubs.ly/Q01NPcC70

Welcome Letizia! Great addition to the team. Ready to collaborate for Alia's future growth!

Great to see our portfolio company, Alia Therapeutics, listed in Sifted's recap of top seed financing rounds in April. Alia Tx just named Letizia Goretti as its new CEO. hubs.ly/Q01N-n3D0 #biotech #geneediting #innovation

Da #Trento uno strumento di precisione per curare il #DNA malato. CIBIO - UniTrento brevetta 'evoCas9', molecola che effettua il taglio di Dna solo nel punto voluto. Lo spiegherà nel #TGR la responsabile della ricerca Anna Cereseto RaiNews Rai Radio1

Congratulations to our colleagues! x.com/NatureBiotech/…

It's World Immunization Week! Vaccine-preventable diseases include: Cervical cancer Cholera Diphtheria Hep B Influenza Japanese encephalitis Measles Mumps Pertussis Pneumonia Polio Rabies Rotavirus Rubella Tetanus Typhoid Varicella Yellow Fever Protected together, #VaccinesWork!

Italia al lavoro per il taglia-incolla del DNA superpreciso Parla la ricercatrice: 'Tecnica più sicura, ma servono fondi' bit.ly/2HVrwue CIBIO - UniTrento Università di Trento